Monday, August 10, 2020

Call Us: (786) 271-5732

JRDS Editorial Board


John J Giordano, Pioneer In Holistic Addiction Treatment, Asked To Join JRDS Editorial Board

John J Giordano, DHL, MAC, a pioneer in holistic addiction treatment and founder/former owner of G & G Holistic Addiction Treatment Center, has accepted Dr. Kenneth Blum’s invitation to join the editorial board of The Journal of Reward Deficiency Syndrome (JRDS). Giordano’s primary responsibility as an editorial board member will be to review papers, thereby providing a consistent level of quality in the reviewing process.


The Journal of Reward Deficiency Syndrome (JRDS) is a new peer-reviewed quarterly published journal that covers the experimental, clinical and epidemiological areas of research which involves the gene associations (including environmental epigenetics) especially the genes involved in brain reward circuitry. It will provide a platform for understanding of the commonality of brain function in substance and non-substance addictive behaviors. In addition to original research, the journal features review articles, clinical studies reports, case reports, hypotheses, letters to editors, articles with novel techniques and book reviews. For more information please visit:

Below you’ll find a list of all the Journal of Reward Deficiency Syndrome (JRDS) Editorial Board Members.

John J Giordano is a pioneer in holistic addiction treatment. He is the founder and former president of G & G Holistic Addiction Treatment Center, a 62 bed in/out patient JCAHO accredited facility located in North Miami Beach, Florida. During his tenure as president, Giordano was one of the first to introduce holistic modalities into the mainstream of addiction treatment. Decades of scientific research has borne out Giordano’s early beliefs that addiction is a mosaic of many seemingly unrelated parts – and each part requires specialized modalities.    

Giordano has contributed to sixty-five papers that have been published in peer reviewed scientific and medical journals. He looks upon this new appointment as an opportunity to further the understanding and effects of Reward Deficiency Syndrome (RDS) in the medical field as well as the public domain. His fervent belief is that a through understanding of RDS is the key to effective addiction treatment and fewer relapses.

John Giordano, DHL And Dr Kenneth Blum are available for interviews by contacting Omni Publicity, Joe Ullrich.

CREDENTIALS: John Giordano is the former president and co-founder of the prestigious G & G Holistic Addiction Treatment Center, a 62 bed in-patient/out-patient JACHO accredited addiction treatment center, he’d started over twenty-years ago, and The National Institute Of Holistic Addiction Studies (NIFHAS). He is the proud recipient of a Doctor Of Human Letters from Sinai University in Jerusalem. Giordano is a recovering addict with twenty-nine years of sobriety to his credit. Mr. Giordano is a therapist, Certified Addiction Professional (CAP), a Master Addictions Counselor (MAC), Certified Eye Movement Desensitization and Reprocessing (EMDR) Specialist, Trauma Relief Specialist (TRT), Certified Hypnotherapist and a Certified Criminal Justice Specialist (CCJS). Mr. Giordano also earned a Masters Certification in Neurolinguistics Programming (NLP). He is a professional expert witness for the state and federal government. John is a Karate Grand Master 10th degree black belt and is in the Karate Hall Of Fame. Mr. Giordano is the chaplain of the North Miami Police Department. For more information please visit http:/


CREDENTIALS: Dr Kenneth Blum made global headlines with his co-discovery of the “Reward Gene,” published by the peer-reviewed Journal of the American Medical Association (JAMA) in 1990. Dr Blum is considered by many as the father of “Psychiatric Genetics” and Neuroadaptagen Amino-Acid Therapy (NAAT). Currently, Dr. Blum is Chairman of the Board and Chief Scientific Officer of LifeGen, Inc. San Diego, California and managing partner of Reward Deficiency Solutions, LLC, and San Diego, California. He was formerly Full Professor of Pharmacology, University of Texas, at San Antonio, Texas for 23 years (retired). He is currently Full Professor of   the Department of Psychiatry and McKnight Brain Institute University of Florida College of Medicine, Gainesville Florida. He served as Research Professor in the Department of Physiology and Pharmacology, Wake forest College of Medicine, Winston-Salem, North Carolina. He serves as scientific Director, PATH Foundation, New York. He has received numerous awards including NIDA Career Teacher Award; American Chemical Society Speakers Award; Gordon Conference Research Award; Presidential Excellence award (National Council of Alcoholism and Drug Abuse). Dr Blum has authored and edited eleven books, was an editor –in –chief of an Elsevier Journal, and has published over 400 peer reviewed papers. Coined “Brain Reward Cascade and Reward Deficiency Syndrome RDS) and is credited as the lead author in the first association of the Dopamine D2 receptor gene with severe alcoholism (JAMA, 1990). Dr. Blum holds both US & foreign patents on Nutrigenomics. He serves on 7 editorial boards and is the associate editor on two boards including section editor of Integrative Omics and Applied Biotechnology journal and is an ad hock reviewer for 40 journals world-wide.

Journal of Reward Deficiency Syndrome (JRDS)

Editorial Board Members

Kenneth Blum, PhD, DHL

University of Florida, USA


Rajendra Badgaiyan, MD

University of Minnesota, USA


Founding Honorary Board

Eric J. Nestler, MD, PhD

Mount Sinai School of Medicine, USA

David E. Comings, MD

City of Hope National Medical Center, USA

Mark S. Gold, MD

University of Florida, USA

Eliot Gardner, PhD

National Institute on Drug Abuse, USA

David E. Smith, MD

University of California at San Francisco, USA

Marc Potenza, MD, PhD

Yale University, USA

Boris Tabakoff, PhD

University of Colorado at Denver, USA

Horace Loh, PhD

University of Minnesota, USA

Marlene Oscar-Berman, PhD

Boston University, USA

Andrew Smolen, PhD

University of Colorado at Boulder, USA

Michael Ritsner, MD

Sha'ar Menashe Mental Health Center, Israel

Philip Gorwood, MD, PhD

Paris Descartes University, France

Tomas Palomo, MD, PhD

Universidad Complutense de Madrid, Spain

Mauro Ceccanti, MD

University of Rome, Italy

Jason Connor, PhD, FAPS

The University of Queensland, Australia

Frederick Toates, DPhil, DSc

The Open University, UK

Mark Griffiths, PhD

Nottingham Trent University, UK

Associate Editorial Board

Panayotis K. Thanos, PhD

SUNY Stony Brook, USA

Marcelo Febo, PhD

University of Florida, USA

Subhash Pandey, PhD

University of Illinois at Chicago, USA

Jhodie Duncan, PhD

University of Melbourne, Australia

Kelvin Lim, MD

University of Minnesota, USA

Zsolt Demetrovics, PhD

Eötvös Loránd University, Hungary

Igor Elman, MD

Harvard Medical School, USA

Thomas Simpatico, MD

University of Vermont, USA

Brett Haberstick, PhD

University of Colorado at Boulder, USA

David Baron, DO, MSEd

USC University, USA

John Femino, MD

Meadows Edge Recovery Center, USA

M. Foster Olive, PhD

Arizona State University, USA

Edward Modestino, PhD

Boston University, USA

A. Kenison Roy, MD

Tulane University Medical School, USA

Sara Jo Nixon, PhD

University of Florida, USA

Debmalya Barh, PhD

Institute of Integrative Omics and Applied Biotechnology, India

Bryan Yamamoto, PhD

University of Toledo, USA

Subject Editors

Eric R. Braverman, MD

University of Florida, USA

Joachim Uys, PhD

Medical University of South Carolina, USA

Wayne Westcott, PhD

Quincy College, USA

Peter R. Martin, MD

Vanderbilt University School of Medicine, USA

William S. Jacobs, MD

Georgia Regents University, USA

Richard Gustin, PhD

Orexo, USA

Daniel H. Angres, MD

Northwestern Feinberg School of Medicine, USA

Pauline Gee, PhD

BodySync, USA

David Han, PhD

University of Texas at San Antonio, USA

Habibeh Khoshbouei, PhD

University of Florida, USA

Adi Jaffe, PhD

Alternatives Behavioral Health, USA

Aviv Weinstein, PhD

Hadassah Medical Organization, Israel

A. Bowirrat, PhD

The Nazareth English Hospital (EMME), Israel

Barry Tolchard, PhD

University of New England, Australia

Deborah Matteliano, PhD

State University of New York, Buffalo, USA

John J. Giordano, DMD

National Institute of Holistic Addiction Studies, USA

Ioannis N. Mavridis, MD, PhD

K.A.T.-N.R.C. General Hospital of Attica, Greece

Thomas McLaughlin, MD

Center For Psychiatric Medicine, Massachusetts, USA

Trevor Archer, PhD

University of Gothenburg, Sweden

Frederick G. Moeller, MD

Virginia Commonwealth University, USA


Our Twitters'

Most Popular

Adrenaline Rush vs. Dopamine Rush

Adrenaline Rush vs. Dopam…

People often confuse an adrenaline rush with a dopamine rush. When someone is confronted with...

How To Be A Successful Addict And Alcoholic

How To Be A Successful Ad…

It never ceases to amaze me just how truly gifted and misguided addicts really are....



THE FUTURE OF ADDICTION TREATMENTI believe Hyperbaric Oxygen Therapy, or HBOT as it's known...



The primary Neurotransmitter Of Reward And Pleasure I'd like to expand on a brief post I...

Our Addictive Society

Our Addictive Society

Thirty-years ago I was as blind to addiction as nearly everyone else walking down the...

Michael Lohan Headline News

Michael Lohan Headline Ne…

Michael Lohan talks G & G Holistic Addiction Treatment Center on Headline News Michael Lohan recommends...

Dopamine – The Single Most Important Word You’ve Never Heard Of

Dopamine – The Single Mos…

Imagine for a moment what it would be like feeling as though you can never...

Highly-Effective, Scientifically-Proven Therapy For PTSD Sufferers

Highly-Effective, Scienti…

The hell like conditions of combat has a wide range of both physical and psychological...

Self-Esteem Effects Every Decision And Choice We Make

Self-Esteem Effects Every…

What is it about our self-esteem that will drive some of us to the outer...

Evidenced Based Scientifically Proven Advancements in Holistic Medicine

Evidenced Based Scientifi…

Addiction treatment is very personal to me. Nearly thirty-years ago it was me who was...

Political DNA

Political DNA

Political DNA: Genetic Differences Between A Liberal And Conservative BrainRecently Dr. Kenneth Blum and myself...

Respectfully President Obama

Respectfully President Ob…

Respectfully President Obama, You Can Shut Down America’s Opiate/Opioid Epidemic Tomorrow – Literally! Last night I...

Are (MAT) Drugs Robbing People Of Their Recovery?

Are (MAT) Drugs Robbing P…

With all due respect to my colleagues who might feel differently, an opioid is an...

Friday April 6 - FOX affiliate WTVT TV

Friday April 6 - FOX affi…

Friday April 6 - FOX affiliate WTVT TVGreat news! My close friend and colleague Dr....



  NATIONAL ALCOHOL AND DRUG ADDICTION RECOVERY MONTH   A time to celebrate our sobriety and accomplishments